FDI-6 is a potent and selective small molecule inhibitor of the FOXM1 transcription factor, disrupting its DNA-binding activity and suppressing downstream target gene expression. Its application in both in vitro and in vivo research models facilitates the study of FOXM1s role in processes such as cell cycle progression and oncogenesis.
